UK Approves First Omicron Vaccine Against COVID-19 –

UK becomes the first country in the world to approve bivalent vaccination Against COVID-19 (new coronavirus infectious disease)which “works” simultaneously for the original and current versions Omicron coronavirus.

On Monday, the UK Medicines Regulatory Authority (MHRA) vaccinationmanufactured by a U.S. pharmaceutical company Moderna, as an adult booster. A marketing authorization for use will be issued shortly.

of vaccination It will be available as a booster in the fall, variant of the SARS-Cov-2 virus that causes COVID-19

The MHRA’s decision was that the booster was “strong immune response“For both Omicron A subvariant (BA.1) and the original Wuhan virus.

in June, Moderna Trial data reported that the variant-adapted injection raised virus-neutralizing antibodies to Omicron eight-fold when administered as the fourth dose.

according to Modernathe adapted variant generated antibody levels against the subvariant that were 1.69-fold higher than those administered with the original booster.

new formula ModernaMHRA added on Monday.

The original vaccine used in the pandemic was designed to train the body to fight the first form of the virus that emerged in Wuhan, China in late 2019. Since then, the virus has mutated significantly, variant include OmicronTo give permission vaccination Protections have to be circumvented, leading to new increases in infected cases.

Everyone over the age of 50, as well as those in high-risk groups, will be offered some form of booster from next month, reports the BBC.

first generation of COVID-19 (new coronavirus infectious disease) Vaccines in use in the UK continue to provide vital protection against disease and save livesMHRA CEO June Lane said in a statement.

what is this bivalent vaccination is an advanced tool to help protect against this disease as the virus continues to evolve..”

follow upon twitter When Facebook

Please contact

Информирайте се на Български –

/ Donevnik. UK Approves First Omicron Vaccine Against COVID-19 –

Back to top button